New Noncovalent Inhibitors of Penicillin-Binding Proteins from Penicillin-Resistant Bacteria
Author Information
Author(s): Turk Samo, Verlaine Olivier, Gerards Thomas, Živec Matej, Humljan Jan, Sosič Izidor, Amoroso Ana, Zervosen Astrid, Luxen André, Joris Bernard, Gobec Stanislav
Primary Institution: Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
Hypothesis
Can novel noncovalent inhibitors effectively target penicillin-binding proteins in resistant bacteria?
Conclusion
New noncovalent inhibitors of PBPs were found, which could lead to the development of more effective treatments for penicillin-resistant bacteria.
Supporting Evidence
- Two compounds showed promising inhibitory activities against PBP2a and PBP2x.
- Compounds were screened from an in-house library of over 250 different chemical classes.
- New inhibitors were identified that could potentially overcome antibiotic resistance.
Takeaway
The researchers found new compounds that can stop bacteria from growing, even those that are resistant to common antibiotics.
Methodology
The study involved screening a library of over 250 compounds for their ability to inhibit penicillin-binding proteins from resistant bacteria.
Limitations
The study primarily focused on in vitro results, which may not fully translate to in vivo effectiveness.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website